Disclosed are abasic modification structures that can be incorporated into oligonucleotides to effectively modulate the expression of a
target gene in a subject while mitigating off-target specificity. Also disclosed are
gene modulators and pharmaceutical compositions comprising the abasic modification structures, as well as methods of using the structures to modulate the expression of a
target gene while mitigating off-target specificity.